What's breaking now, across thousands of outlets.
U.S. regulators have accepted a new submission for Vyglxia, offering the chance at a turnaround for another rare disease medicine spurned by previous FDA leadership.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
A needle-free vaccination method protected mice against the viruses that cause COVID-19 and flu, offering a possible new way to deliver mRNA vaccines while limiting unwanted inflammation.
It’s the latest insurer to report momentum in the safety-net insurance program as states increase their payment rates and costs plateau.
RIYADH — The Ministry of Health has affirmed that reviewing prescriptions and verifying medication safety are among the pharmacist’s core responsibilities.
The acquisition is set to give Integris access to extra capital and technology at a time when many health systems are being hit by rising expenses.
(MedPage Today) -- No patient today should face the risk of acquiring HIV. That means we need to focus our attention on people who could benefit from HIV preexposure prophylaxis (PrEP) but are not…
Roche is gearing up for a major launch in the shape of its breast cancer pill giredestrant, and according to Teresa Graham, head of the company’s pharma unit, patients are clamoring to get hold of ...
